KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Change in Inventory (2016 - 2025)

Historic Change in Inventory for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to -$2.0 million.

  • AbbVie's Change in Inventory fell 10312.5% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $337.0 million, marking a year-over-year increase of 25473.68%. This contributed to the annual value of $319.0 million for FY2024, which is 2350.12% down from last year.
  • Per AbbVie's latest filing, its Change in Inventory stood at -$2.0 million for Q3 2025, which was down 10312.5% from $56.0 million recorded in Q2 2025.
  • AbbVie's 5-year Change in Inventory high stood at $385.0 million for Q1 2022, and its period low was -$219.0 million during Q3 2021.
  • Moreover, its 5-year median value for Change in Inventory was $75.0 million (2024), whereas its average is $93.3 million.
  • As far as peak fluctuations go, AbbVie's Change in Inventory tumbled by 15647.06% in 2023, and later surged by 23333.33% in 2024.
  • AbbVie's Change in Inventory (Quarter) stood at $112.0 million in 2021, then soared by 51.79% to $170.0 million in 2022, then crashed by 156.47% to -$96.0 million in 2023, then soared by 233.33% to $128.0 million in 2024, then tumbled by 101.56% to -$2.0 million in 2025.
  • Its Change in Inventory was -$2.0 million in Q3 2025, compared to $56.0 million in Q2 2025 and $155.0 million in Q1 2025.